352
Views
11
CrossRef citations to date
0
Altmetric
Review

Vaccine-preventable infection morbidity of patients with chronic kidney disease and cocoon vaccination strategies

&

References

  • Bonanni P, Sacco C, Donato R, Capei R. Lifelong vaccination as a key disease-prevention strategy. Clin Microbiol Infect 2014;20(Suppl 5):32-6
  • Lessin HR, Edwards KM; Committee On Practice And Ambulatory Medicine; Committee On Infectious Diseases. Immunizing parents and other close family contacts in the pediatric office setting. Pediatrics 2012;129(1):e247-53
  • Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005;24(Suppl 5):S58-61
  • Esposito S, Mastrolia MV, Prada E, et al. Vaccine administration in children with chronic kidney disease. Vaccine. 2014;32(49):6601-6
  • Mathew R, Mason D, Kennedy JS. Vaccination issues in patients with chronic kidney disease. Expert Rev Vaccines 2014;13(2):285-98
  • Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67(6):2089-100
  • Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 2005;16(12):3736-41
  • Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol 2012;27(3):363-73
  • Dalrymple LS, Go AS. Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol 2008;3(5):1487-93
  • Centers for Disease Control and Prevention (CDC). Noninfluenza vaccination coverage among adults - United States, 2011. MMWR Morb Mortal Wkly Rep 2013;62(4):66-72
  • Esposito S, Durando P, Bosis S, ESCMID Vaccine Study Group (EVASG). Vaccine-preventable diseases: from paediatric to adult targets. Eur J Intern Med 2014;25(3):203-12
  • Grizas AP, Camenga D, Vázquez M. Cocooning: a concept to protect young children from infectious diseases. Curr Opin Pediatr 2012;24(1):92-7
  • Rowe SL, Cunningham HM, Franklin LJ, Lester RA. Uptake of a government-funded pertussis-containing booster vaccination program for parents of new babies in Victoria. Australia. Vaccine 2015;33(15):1791-6
  • Simonetti A, Martini I, Bonomo G, et al. Improving adherence rates to a cocooning program: a pilot experience in Italy. Hum Vaccin Immunother 2013;9(5):1142-5
  • Munoz F, Englund J. Infant pertussis: is cocooning the answer? Clin Infect Dis 2011;53(9):89389-6
  • Fernández-Cano MI, Armadans Gil L, Campins Martí M. Cost-benefit of the introduction of new strategies for vaccination against pertussis in Spain: Cocooning and pregnant vaccination strategies. Vaccine 2015;33(19):2213-20
  • Maltezou HC, Kalogriopoulou K, Pergialiotis V, et al. Acceptance of a post-partum influenza vaccination (cocooning) strategy for neonates in Greece. Vaccine 2012;30(40):5871-4
  • Urwyler P, Heininger U. Protecting newborns from pertussis - the challenge of complete cocooning. BMC Infect Dis 2014;14:397
  • Chiappini E, Stival A, Galli L, de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis 2013;13:151
  • Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines. Recommendations of the advisory committee on immunization practices–United States, 2013-2014. MMWR Morb Mortal Wkly Rep 2013;62(RR-07):1-43
  • Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol 2014;38-42
  • Reichert TA, Sugaya N, Fedson DS, et al. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001;344(912):889-96
  • Crawford NW, Bines JE, Royle J, Buttery JP. Optimizing immunization in pediatric special risk groups. Expert Rev Vaccines 2011;10(2):175-86
  • Vaccines that might be indicated for adults based on medical and other indications. Available from: www.cdc.gov/vaccines/schedules/hcp/imz/adult-conditions.html [Last accessed 21 May 2015]
  • Betsch C. Overcoming healthcare workers vaccine refusal–competition between egoism and altruism. Euro Surveill 2014;19(48):20979
  • Abramson ZH. What, in fact, is the evidence that vaccinating healthcare workers against seasonal influenza protects their patients? A Critical Review Int J Family Med 2012;2012:205464
  • Galanakis E, D’Ancona F, Jansen A, Lopalco PL; VENICE (Vaccine European New Integrated Collaboration Effort) National Gatekeepers, Contact Points. The issue of mandatory vaccination for healthcare workers in Europe. Expert Rev Vaccines 2014;13(2):277-83
  • United States Renal Data System, 2014 USRDS annual data report: An overview of the epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD: 2014
  • Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298(17):2038-47
  • Edvardsson VO, Goldfarb DS, Lieske JC, et al. Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol 2013;28(10):1923-42
  • Shroff A, Frank R, Vergara M, et al. Prevention of serious bacterial infections in new-onset nephrotic syndrome: a survey of current practices. Clin Pediatr (Phila) 2002;41(1):47-9
  • Uncu N, Bülbül M, Yildiz N, et al. Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study. Eur J Pediatr 2010;169(1):73-6
  • Beck L, Bomback AS, Choi MJ, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis. Am J Kidney Dis 2013;62(3):403-41
  • Dharnidharka VR, Fiorina P, Harmon WE. Kidney transplantation in children. N Engl J Med 2014;371(6):549-58
  • Kato S, Chmielewski M, Honda H, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008;3(5):1526-33
  • Silverstein DM. Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol 2009;24(8):1445-52
  • Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr 2012;22(1):149-56
  • Agrawal S, Gollapudi P, Elahimehr R, et al. Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. Nephrol Dial Transplant 2010;25(3):737-46
  • Sui W, Tan J, Guo J, et al. An altered TH1/TH2 and pro-inflammatory cytokine profile in patients with end-stage renal disease detected by suspension array technology. Ren Fail 2009;31(1):1-5
  • Betjes MG, Langerak AW, van der Spek A, et al. Premature aging of circulating T cells in patients with end-stage renal disease. Kidney Int 2011;80(2):208-17
  • Li PK, Chow KM. Infectious complications in dialysis–epidemiology and outcomes. Nat Rev Nephrol 2011;8(2):77-88
  • Bouts AH, Davin JC, Krediet RT, et al. Immunoglobulins in chronic renal failure of childhood: effects of dialysis modalities. Kidney Int 2000;58(2):629-37
  • Kausz AT, Gilbertson DT. Overview of vaccination in chronic kidney disease. Adv Chronic Kidney Dis 2006;13(3):209-14
  • Naqvi SB, Collins AJ. Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis 2006;13(3):199-204
  • Chavers BM, Solid CA, Gilbertson DT, Collins AJ. Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States. J Am Soc Nephrol 2007;18(3):952-9
  • Mitsnefes MM, Laskin BL, Dahhou M, et al. Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010. JAMA 2013;309(18):1921-9
  • Allon M, Depner TA, Radeva M, et al. Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol 2003;14(7):1863-70
  • Mencarelli F, Marks SD. Non-viral infections in children after renal transplantation. Pediatr Nephrol 2012;27(9):1465-76
  • Fishman JA. Infection in renal transplant recipients. Semin Nephrol 2007;27(4):445-61
  • Soni R, Horowitz B, Unruh M. Immunization in end-stage renal disease: opportunity to improve outcomes. Semin Dial 2013;26(4):416-26
  • Yassin MH, Gupta V. Role of infection control in prevention of hepatitis B virus (HBV) in hemodialysis (HD) patients. Infect Disord Drug Targets 2013;13(3):162-8
  • Chow KM, Law MC, Leung CB, et al. Antibody response to hepatitis B vaccine in end-stage renal disease patients. Nephron Clin Pract 2006;103(3):c89-93
  • Mantan M, Pandharikar N, Yadav S, et al. Seroprotection for hepatitis B in children with nephrotic syndrome. Pediatr Nephrol 2013;28(11):2125-30
  • Tsouchnikas I, Dounousi E, Xanthopoulou K, et al. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination. Clin Nephrol 2007;68(4):228-34
  • Leroux-Roels G. Old and new adjuvants for hepatitis B vaccines. Med Microbiol Immunol 2015;204(1):69-78
  • Jeon HJ, Ro H, Jeong JC, et al. Efficacy and safety of hepatitis A vaccination in kidney transplant recipients. Transpl Infect Dis 2014;16(3):511-15
  • Danziger-Isakov L, Kumar D. AST Infectious Diseases Community of Practice. Vaccination in solid organ transplantation. Am J Transplant 2013;13(Suppl 4):311-7
  • Fleischmann EH, Kruppenbacher J, Bock HL, Weber M. Active immunization against hepatitis A in dialysis patients. Nephrol Dial Transplant 2002;17(10):1825-8
  • Gutiérrez Rodríguez M, Varela González A, Ordobás Gavín M, et al. Invasive pneumococcal disease: Association between serotype, clinical presentation and lethality. Vaccine 2011;29:5740-6
  • Cho BH, Stoecker C, Link-Gelles R, Moore MR. Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions. Vaccine 2013;31(50):6011-21
  • Germinario C, Gallone MS, Cappelli MG, Tafuri S. Clinical benefits of routine varicella vaccination for adults. Hum Vaccin Immunother 2015. [Epub ahead of print]
  • Fadrowski JJ, Furth SL. Varicella zoster virus: vaccination and implications in children with renal failure. Expert Rev Vaccines 2004;3(3):291-8
  • Lang PO, Aspinall R. Vaccination in the elderly: what can be recommended? Drugs Aging 2014;31(8):581-99
  • Wallinga J, Heijne JC, Kretzschmar M. A measles epidemic threshold in a highly vaccinated population. PLoS Med 2005;2(11):e316
  • Allam MF. New measles vaccination schedules in the European countries? J Prev Med Hyg 2014;55(1):33-4
  • Neu AM. Immunization in children with chronic renal failure. Pediatr Nephrol 2012;8:1257-63
  • Skov Dalgaard L, Fassel U, Østergaard LJ, et al. Risk of human papillomavirus-related cancers among kidney transplant recipients and patients receiving chronic dialysis–an observational cohort study. BMC Nephrol 2013;14:137
  • Kumar D, Unger ER, Panicker G, et al. Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients. Am J Transplant 2013;13(9):2411-17
  • Dinits-Pensy M, Forrest GN, Cross AS, Hise MK. The use of vaccines in adult patients with renal disease. Am J Kidney Dis 2005;46(6):997-1011
  • Kotton CN. Immunization after kidney transplantation-what is necessary and what is safe? Nat Rev Nephrol 2014;10(10):555-62
  • Mathew R, Mason D, Kennedy JS. Vaccination issues in patients with chronic kidney disease. Expert Rev Vaccines 2014;13(2):285-98
  • Neuhaus TJ. Immunization in children with chronic renal failure: a practical approach. Pediatr Nephrol 2004;19(12):1334-9
  • Edey M, Barraclough K, Johnson DW. Review article: Hepatitis B and dialysis. Nephrology (Carlton) 2010;15(2):137-45
  • Abeyagunawardena AS, Goldblatt D, Andrews N, Trompeter RS. Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Lancet 2003;362(9382):449-50
  • Taylor B, Andrews N, Stowe J, et al. No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Arch Dis Child 2007;92(10):887-9
  • Yıldız N, Sever L, Kasapçopur Ö, et al. Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: immunogenicity and safety? Vaccine 2013;31(33):3309-12
  • Kamboj M, Sepkowitz KA. Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient. Infect Control Hosp Epidemiol 2007;28(6):702-7
  • Sester M, Gärtner BC, Girndt M, Sester U. Vaccination of the solid organ transplant recipient. Transplant Rev (Orlando) 2008;22(4):274-84
  • Campbell AL, Herold BC. Immunization of pediatric solid-organ transplantation candidates: immunizations in transplant candidates. Pediatr Transplant 2005;9(5):652-61
  • Esposito S, Principi N, Cornaglia G; ESCMID Vaccine Study Group (EVASG). Barriers to the vaccination of children and adolescents and possible solutions. Clin Microbiol Infect 2014;20(Suppl 5):25-31
  • Dubé E, Laberge C, Guay M, et al. Vaccine hesitancy: an overview. Hum Vaccin Immunother 2013;9(8):1763-73
  • Kausz AT, Guo H, Pereira BJ, et al. General medical care among patients with chronic kidney disease: opportunities for improving outcomes. J Am Soc Nephrol 2005;16(10):3092-101
  • Nakopoulou L, Stefanaki K, Zeis PM, et al. The frequency of hepatitis B virus infection in Greek patients with various types of glomerulonephritis. Eur J Epidemiol 1994;10(6):737-42
  • Avery RK. Influenza vaccines in the setting of solid-organ transplantation: are they safe? Curr Opin Infect Dis 2012;25(4):464-8
  • Verolet CM, Posfay-Barbe KM. Live virus vaccines in transplantation: friend or foe? Curr Infect Dis Rep 2015;17(4):472
  • Danerseau AM, Robinson JL. Efficacy and safety of measles, mumps, rubella and varicella live viral vaccines in transplant recipients receiving immunosuppressive drugs. World J Pediatr 2008;4(4):254-8
  • Monaro S, Stewart G, Gullick J. A ’lost life’: coming to terms with haemodialysis. J Clin Nurs 2014;23(21-22):3262-73
  • Tong A, Lesmana B, Johnson DW, et al. The perspectives of adults living with peritoneal dialysis: thematic synthesis of qualitative studies. Am J Kidney Dis 2013;61(6):873-88
  • Keeney S, McKenna H. An exploration of the choices of patients with chronic kidney disease. Patient Prefer Adherence 2014;8:1465-74
  • Morton RL, Tong A, Howard K, et al. The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. BMJ 2010;19: 340,c112
  • MacDonald H. Chronic renal disease: the mother’s experience. Pediatr Nurs 1995;21(6):503-7
  • Naderi M, Gholipour N, Zolfaghari MR, et al. Hepatitis C virus and vaccine development. Int J Mol Cell Med 2014;3(4):207-15
  • McVoy MA. Cytomegalovirus vaccines. Clin Infect Dis 2013;57(Suppl 4):S196-9
  • Rapicetta M, D’Ugo E, Argentini C, et al. New perspectives for hepatitis B vaccines and immunization. Vaccine 2009;27(25-26):3271-5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.